✦ LIBER ✦

Progression-free survival as an end-point in clinical trials of biotherapeutic agents

✍ Scribed by Lothar Bergmann; Steven Hirschfeld; Charles Morris; Sergio Palmeri; Andrew Stone

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Progression-free survival as an end-poin

✍ Robinson, Andrew G.; Booth, Christopher M.; Eisenhauer, Elizabeth A. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 375 KB

Progression-free survival versus overall

✍ Maurie Markman 📂 Article 📅 2008 🏛 Current Science Inc. 🌐 English ⚖ 192 KB

Disease-free survival as an end-point in

✍ Robinson, Andrew G.; Booth, Christopher M.; Eisenhauer, Elizabeth A. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 326 KB

Use of progression-free survival as a va

✍ Maurie Markman 📂 Article 📅 2007 🏛 Current Science Inc. 🌐 English ⚖ 86 KB

Progression-free rate as the principal e

✍ M Van Glabbeke; J Verweij; I Judson; O.S Nielsen 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 115 KB

Impact of phase II trials with progressi

✍ Victor A Levin; Sandra Ictech; Kenneth R Hess 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 343 KB